Review
Aug 2026
The gut microbiota-miRNA axis in multiple sclerosis: Mechanisms and therapeutic potentials.
A better understanding of the GM-miRNA axis may facilitate the development of novel biomarkers and personalized therapeutic strategies, ultimately shifting MS management from symptomatic treatment toward precision, disease-modifying interventions.
Farzaneh Rafie Sedaghat, A. Hasani, V. Poortahmasebi et al.
· Folia Microbiologica (Prague... · 0 citations